Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
3
×
life sciences
amgen
biotech
boston top stories
clinical trials
mark timney
national blog main
national top stories
new york blog main
new york top stories
novartis
san francisco blog main
san francisco top stories
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amarin
aridis pharmaceuticals
aristea therapeutics
autoimmune diseases
axitinib
bellus health
bioinnovation capital
biolabs
biotech ipos
bolt biotherapeutics
boston
boulder/denver blog main
boulder/denver top stories
bridgebio
bristol-myers squibb
cancer
cell therapy
chemotherapy
What
drug
pricing
3
×
aces
advantages
announced
bar
big
bio
biotech
brings
ceo
cholesterol
driving
expect
flexible
gamble
good
healthcare
history
improved
inclisiran
industry
innovation
innovations
investment
key
life
long
lowering
market
meant
medco
medco’s
medical
medicine
medicines
mover
nasdaq
new
open
Language
unset
3
×
Current search:
pricing
×
unset
×
" boston blog main "
×
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
